Glycopyrrolate + Indacaterol bulk supplier for pharma manufacturers

Glycopyrrolate + Indacaterol Suppliers & Bulk Manufacturers

Available Forms: Inhalation powder delivered via Neohaler device/Breezhaler device

Available Strengths: Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg

Reference Brands: Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU)

Glycopyrrolate + Indacaterol is a dual bronchodilator used for long-term COPD management. It combines a LAMA and LABA to improve breathing and reduce symptoms. Sold as Ultibro Breezhaler in the EU, it offers once-daily relief and better lung function, but is not for acute symptom relief.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Glycopyrrolate + Indacaterol is a dual bronchodilator combination used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). Glycopyrrolate is a long-acting muscarinic antagonist (LAMA), while Indacaterol is a long-acting beta2-agonist (LABA). Together, they provide effective, once-daily bronchodilation, improving lung function and reducing COPD symptoms like breathlessness. Marketed under brand names such as Ultibro Breezhaler in the EU and previously as Utibron Neohaler in the US, this inhalation therapy offers enhanced respiratory relief. It is not intended for acute symptom relief but plays a vital role in COPD management by optimizing airflow and improving patients’ quality of life.

Glycopyrrolate + Indacaterol — third party manufacturing & bulk supply

Glycopyrrolate + Indacaterol is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Glycopyrrolate + Indacaterol is supplied as Inhalation powder delivered via Neohaler device/Breezhaler device — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glycopyrrolate + Indacaterol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Glycopyrrolate + Indacaterol →

Back to Listing

Frequently Asked Questions

Glycopyrrolate + Indacaterol is listed as Inhalation powder delivered via Neohaler device/Breezhaler device in Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Glycopyrrolate + Indacaterol is referenced against Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.